BOK Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.93M | Sell |
8,918
-801
| -8% | -$153K | 0.03% | 333 |
|
|
2026
Q1 | $1.78M | Sell |
9,719
-5,149
| -35% | -$949K | 0.03% | 338 |
|
|
2025
Q4 | $2.62M | Sell |
14,868
-5,412
| -27% | -$884K | 0.04% | 287 |
|
|
2025
Q3 | $2.84M | Sell |
20,280
-1,131
| -5% | -$153K | 0.04% | 286 |
|
|
2025
Q2 | $2.69M | Sell |
21,411
-1,251
| -6% | -$156K | 0.04% | 298 |
|
|
2025
Q1 | $3.1M | Buy |
22,662
+1,810
| +9% | +$259K | 0.05% | 263 |
|
|
2024
Q4 | $3.1M | Sell |
20,852
-3,357
| -14% | -$566K | 0.05% | 263 |
|
|
2024
Q3 | $4.47M | Sell |
24,209
-619
| -2% | -$130K | 0.08% | 214 |
|
|
2024
Q2 | $5.76M | Sell |
24,828
-970
| -4% | -$211K | 0.1% | 181 |
|
|
2024
Q1 | $5.54M | Sell |
25,798
-8,556
| -25% | -$2M | 0.1% | 196 |
|
|
2023
Q4 | $8.89M | Sell |
34,354
-8,607
| -20% | -$2.11M | 0.17% | 129 |
|
|
2023
Q3 | $10.2M | Buy |
42,961
+15,583
| +57% | +$4.17M | 0.22% | 97 |
|
|
2023
Q2 | $7.8M | Buy |
27,378
+5,424
| +25% | +$1.61M | 0.16% | 142 |
|
|
2023
Q1 | $6.1M | Sell |
21,954
-6,894
| -24% | -$1.91M | 0.13% | 170 |
|
|
2022
Q4 | $7.99M | Buy |
28,848
+147
| +0.5% | +$41.5K | 0.15% | 143 |
|
|
2022
Q3 | $7.66M | Buy |
28,701
+9,421
| +49% | +$2M | 0.16% | 140 |
|
|
2022
Q2 | $3.93M | Sell |
19,280
-72
| -0.4% | -$14.7K | 0.08% | 237 |
|
|
2022
Q1 | $4.08M | Sell |
19,352
-20
| -0.1% | -$4.35K | 0.07% | 263 |
|
|
2021
Q4 | $4.65M | Sell |
19,372
-7,135
| -27% | -$1.83M | 0.07% | 252 |
|
|
2021
Q3 | $7.5M | Buy |
+26,507
| New | +$8.69M | 0.13% | 172 |
|
|
2021
Q1 | $5.34M | Sell |
19,088
-1,509
| -7% | -$407K | 0.1% | 202 |
|
|
2020
Q4 | $5.04M | Buy |
20,597
+4,546
| +28% | +$1.17M | 0.1% | 202 |
|
|
2020
Q3 | $4.55M | Buy |
16,051
+4,806
| +43% | +$1.34M | 0.1% | 198 |
|
|
2020
Q2 | $3.01M | Buy |
11,245
+7,629
| +211% | +$2.29M | 0.07% | 254 |
|
|
2020
Q1 | $1.14M | Buy |
3,616
+644
| +22% | +$195K | 0.03% | 395 |
|
|
2019
Q4 | $882K | Sell |
2,972
-378
| -11% | -$105K | 0.02% | 544 |
|
|
2019
Q3 | $780K | Sell |
3,350
-2,309
| -41% | -$538K | 0.02% | 564 |
|
|
2019
Q2 | $1.32M | Sell |
5,659
-504
| -8% | -$116K | 0.03% | 427 |
|
|
2019
Q1 | $1.46M | Sell |
6,163
-8,282
| -57% | -$2.61M | 0.03% | 404 |
|
|
2018
Q4 | $4.35M | Sell |
14,445
-1,497
| -9% | -$478K | 0.12% | 184 |
|
|
2018
Q3 | $5.63M | Sell |
15,942
-3,708
| -19% | -$1.28M | 0.14% | 182 |
|
|
2018
Q2 | $5.7M | Buy |
19,650
+2,996
| +18% | +$842K | 0.15% | 160 |
|
|
2018
Q1 | $4.56M | Buy |
16,654
+1,141
| +7% | +$354K | 0.13% | 186 |
|
|
2017
Q4 | $4.94M | Sell |
15,513
-10
| -0.1% | -$3.21K | 0.14% | 177 |
|
|
2017
Q3 | $4.86M | Buy |
15,523
+217
| +1% | +$64.3K | 0.14% | 168 |
|
|
2017
Q2 | $4.15M | Sell |
15,306
-784
| -5% | -$207K | 0.13% | 185 |
|
|
2017
Q1 | $4.4M | Sell |
16,090
-387
| -2% | -$109K | 0.14% | 173 |
|
|
2016
Q4 | $4.67M | Buy |
16,477
+2,505
| +18% | +$743K | 0.15% | 151 |
|
|
2016
Q3 | $4.37M | Buy |
13,972
+5,923
| +74% | +$1.75M | 0.14% | 161 |
|
|
2016
Q2 | $1.95M | Sell |
8,049
-1,517
| -16% | -$400K | 0.07% | 305 |
|
|
2016
Q1 | $2.49M | Sell |
9,566
-8,417
| -47% | -$2.22M | 0.09% | 262 |
|
|
2015
Q4 | $5.51M | Sell |
17,983
-4,858
| -21% | -$1.4M | 0.2% | 125 |
|
|
2015
Q3 | $6.67M | Sell |
22,841
-12,389
| -35% | -$4.09M | 0.25% | 92 |
|
|
2015
Q2 | $14.2M | Buy |
35,230
+13,967
| +66% | +$5.61M | 0.48% | 42 |
|
|
2015
Q1 | $8.98M | Buy |
21,263
+1,117
| +6% | +$440K | 0.3% | 80 |
|
|
2014
Q4 | $6.84M | Buy |
20,146
+1,757
| +10% | +$568K | 0.24% | 105 |
|
|
2014
Q3 | $6.08M | Buy |
18,389
+5,140
| +39% | +$1.69M | 0.2% | 110 |
|
|
2014
Q2 | $4.18M | Buy |
13,249
+525
| +4% | +$158K | 0.13% | 173 |
|
|
2014
Q1 | $3.89M | Sell |
12,724
-711
| -5% | -$226K | 0.13% | 177 |
|
|
2013
Q4 | $3.76M | Buy |
13,435
+900
| +7% | +$233K | 0.13% | 181 |
|
|
2013
Q3 | $3.02M | Sell |
12,535
-3,762
| -23% | -$842K | 0.11% | 202 |
|
|
2013
Q2 | $3.51M | Buy |
+16,297
| New | +$3.48M | 0.13% | 163 |
|
Other funds holding BIIB
BOK Financial's BIIB Position: Q2 2026 in Review
BOK Financial reduced its Biogen (BIIB) stake by 8.2% in Q2 2026, selling an estimated $153K and leaving 8,918 shares worth $1.93M. The position accounts for 0.03% of the portfolio, ranked #333.
BOK Financial first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.2M in Q2 2015. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- BOK Financial held 8,918 shares of Biogen worth $1.93M as of Q2 2026.
- BOK Financial sold 801 Biogen shares in Q2 2026, an estimated $153K.
- Biogen made up 0.03% of BOK Financial's portfolio in Q2 2026, its #333 holding.
- BOK Financial first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- BOK Financial's Biogen position peaked at $14.2M in Q2 2015.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.